Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisRaoul Herbrecht, Ben de Pauw, David W. Denning et al.|New England Journal of Medicine|2002Cited by 3.3k
Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trialJuliette Lambert, Sylvie Castaigné, Ollivier Legrand et al.|Haematologica|2018Cited by 349
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association GroupMarie Balsat, Nicolas Boissel, Aline Renneville et al.|Journal of Clinical Oncology|2017Cited by 292